SCOPODERM TTS 1 mg/72 hours, medicated transdermal patch 5 patches in individual sachets
Active ingredients: L-scopolamine
Commercialized according to BDPMDispensing in France: Prescription only
Medicated transdermal patch5 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SCOPODERM TTS 1 mg/72 heures, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- un étui de 5 sachets aluminium de 1 dispositif
- Marketing authorisation holder
- BB FARMA (ITALIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63034382CIP74900343CIP133400949003433Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SCOPOLAMINEdispositif | 0,25 mg · un dispositif transdermique | SA |
| SCOPOLAMINEdispositif | 1,26 mg · un dispositif transdermique | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.